ASX:CHM

Chimeric Therapeutics Competitors

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Chimeric Therapeutics (ASX:CHM) Vs. CHV, DDXS, PREV, TNGN, COM, and MYM

Should you be buying CHM stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Chimeric Therapeutics, including (CHV) (CHV), (DDXS) (DDXS), (PREV) (PREV), (TNGN) (TNGN), 138267 (COM.TO) (COM), and 17031 (MYM).

Chimeric Therapeutics (ASX:CHM) and (CHV) (CNSX:CHV) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, risk and analyst recommendations.

Earnings & Valuation

This table compares Chimeric Therapeutics and (CHV)'s top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Chimeric TherapeuticsN/AN/AN/AN/AN/A
(CHV)N/AN/AN/AN/AN/A

Profitability

This table compares Chimeric Therapeutics and (CHV)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Chimeric TherapeuticsN/AN/AN/A
(CHV)N/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Chimeric Therapeutics and (CHV), as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Chimeric Therapeutics0000N/A
(CHV)0000N/A

Chimeric Therapeutics (ASX:CHM) and (DDXS) (OTCMKTS:DDXS) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, risk and analyst recommendations.

Earnings & Valuation

This table compares Chimeric Therapeutics and (DDXS)'s top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Chimeric TherapeuticsN/AN/AN/AN/AN/A
(DDXS)N/AN/AN/AN/AN/A

Profitability

This table compares Chimeric Therapeutics and (DDXS)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Chimeric TherapeuticsN/AN/AN/A
(DDXS)N/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Chimeric Therapeutics and (DDXS), as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Chimeric Therapeutics0000N/A
(DDXS)0000N/A

Chimeric Therapeutics (ASX:CHM) and (PREV) (CNSX:PREV) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, risk and analyst recommendations.

Earnings & Valuation

This table compares Chimeric Therapeutics and (PREV)'s top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Chimeric TherapeuticsN/AN/AN/AN/AN/A
(PREV)N/AN/AN/AN/AN/A

Profitability

This table compares Chimeric Therapeutics and (PREV)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Chimeric TherapeuticsN/AN/AN/A
(PREV)N/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Chimeric Therapeutics and (PREV), as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Chimeric Therapeutics0000N/A
(PREV)0000N/A

Chimeric Therapeutics (ASX:CHM) and (TNGN) (OTCMKTS:TNGN) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, risk and analyst recommendations.

Earnings & Valuation

This table compares Chimeric Therapeutics and (TNGN)'s top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Chimeric TherapeuticsN/AN/AN/AN/AN/A
(TNGN)N/AN/AN/AN/AN/A

Profitability

This table compares Chimeric Therapeutics and (TNGN)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Chimeric TherapeuticsN/AN/AN/A
(TNGN)N/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Chimeric Therapeutics and (TNGN), as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Chimeric Therapeutics0000N/A
(TNGN)0000N/A

Chimeric Therapeutics (ASX:CHM) and 138267 (COM.TO) (TSE:COM) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, risk and analyst recommendations.

Earnings & Valuation

This table compares Chimeric Therapeutics and 138267 (COM.TO)'s top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Chimeric TherapeuticsN/AN/AN/AN/AN/A
138267 (COM.TO)N/AN/AN/AN/AN/A

Profitability

This table compares Chimeric Therapeutics and 138267 (COM.TO)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Chimeric TherapeuticsN/AN/AN/A
138267 (COM.TO)N/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Chimeric Therapeutics and 138267 (COM.TO), as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Chimeric Therapeutics0000N/A
138267 (COM.TO)0000N/A

Chimeric Therapeutics (ASX:CHM) and 17031 (CNSX:MYM) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, risk and analyst recommendations.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Chimeric Therapeutics and 17031, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Chimeric Therapeutics0000N/A
170310000N/A

Earnings & Valuation

This table compares Chimeric Therapeutics and 17031's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Chimeric TherapeuticsN/AN/AN/AN/AN/A
17031N/AN/AN/AN/AN/A

Profitability

This table compares Chimeric Therapeutics and 17031's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Chimeric TherapeuticsN/AN/AN/A
17031N/AN/AN/A


Chimeric Therapeutics Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
CHV
(CHV)
0.5N/AN/A$0.00N/A0.00High Trading Volume
News Coverage
(DDXS) logo
DDXS
(DDXS)
0.5$0.00flat$0.00N/A0.00
PREV
(PREV)
0.7N/AN/A$0.00N/A0.00High Trading Volume
TNGN
(TNGN)
0.4N/AN/A$0.00N/A0.00Gap Down
COM
138267 (COM.TO)
0.5N/AN/AC$0.00N/A0.00
MYM
17031
0.4N/AN/AC$0.00N/A0.00
Abattis Bioceuticals logo
ATTBF
Abattis Bioceuticals
0.4$0.02flat$0.00N/A0.00Gap Down
Abzena logo
ABZA
Abzena
0.6$15.75flat£0.00N/A0.00
ACR
Acrux
0.9N/AN/A$0.00$1.61 million0.00High Trading Volume
News Coverage
Gap Down
ACW
Actinogen Medical
0.5N/AN/A$0.00$2.84 million0.00High Trading Volume
Gap Down
1AD
AdAlta
0.5N/AN/A$0.00$4.23 million0.00High Trading Volume
Gap Down
ADiTx Therapeutics logo
ADTX
ADiTx Therapeutics
1.0$2.84flat$0.00N/A0.00Increase in Short Interest
Gap Down
AHZ
Admedus
0.5N/AN/A$0.00N/A0.00High Trading Volume
Algernon Pharmaceuticals logo
AGNPF
Algernon Pharmaceuticals
0.0$0.13flat$0.00N/A0.00Gap Up
Almirall logo
LBTSF
Almirall
0.5$15.15flat$0.00N/A0.00News Coverage
AMBS
Amarantus BioScience
0.5N/AN/A$0.00N/A0.00High Trading Volume
ATX
Amplia Therapeutics
0.8N/AN/A$0.00$894,155.000.00High Trading Volume
Gap Down
ANR
Anatara Lifesciences
0.5N/AN/A$0.00$268,259.000.00High Trading Volume
Gap Down
ANVS
Annovis Bio
0.0N/AN/A$0.00N/A0.00High Trading Volume
News Coverage
Apotheca Biosciences logo
CBDC
Apotheca Biosciences
0.4$0.06flat$0.00N/A0.00High Trading Volume
Gap Down
ARNI
Arno Therapeutics
0.5$0.01flat$0.00N/A0.00
ASCLF
Ascletis Pharma
0.4$0.37flat$0.00N/A0.00News Coverage
Avid Bioservices logo
CDMOP
Avid Bioservices
0.3$25.06flat$0.00N/A0.00
AXIM Biotechnologies logo
AXIM
AXIM Biotechnologies
0.4$0.62flat$0.00N/A0.00
BXRXV
Baudax Bio
0.5N/AN/A$0.00N/A0.00High Trading Volume
News Coverage
BerGenBio ASA logo
BRRGF
BerGenBio ASA
0.7$3.52flat$0.00N/A0.00
BGT
Bio-Gene Technology
0.8N/AN/A$0.00$82,795.000.00High Trading Volume
Gap Down
BNO
Bionomics
0.5N/AN/A$0.00$2.19 million0.00High Trading Volume
Gap Down
BIT
Biotron
0.5N/AN/A$0.00$853,026.000.00High Trading Volume
Gap Down
BXN
Bioxyne
0.5N/AN/A$0.00$2.18 million0.00High Trading Volume
Gap Down
BOT
Botanix Pharmaceuticals
0.5N/AN/A$0.00$6.89 million0.00High Trading Volume
Gap Down
BPH
BPH Energy
0.5N/AN/A$0.00$106,954.000.00High Trading Volume
Gap Down
BTC
BTC Health
0.8N/AN/A$0.00$131,934.000.00High Trading Volume
Gap Down
Cannabics Pharmaceuticals logo
CNBX
Cannabics Pharmaceuticals
0.4$0.21flat$0.00N/A0.00Gap Up
ORHOF
CannaRoyalty
0.7$9.23flat$0.00N/A0.00Gap Up
CDXI
Cardax
0.0N/AN/A$0.00N/A0.00High Trading Volume
CDY
Cellmid
0.5N/AN/A$0.00$6.61 million0.00High Trading Volume
Gap Down
Cerebain Biotech logo
CBBT
Cerebain Biotech
0.0$0.05flat$0.00N/A0.00
CGYG
China Longyi Group International
0.4$0.00flat$0.00N/A0.00
CLVLY
Clinuvel Pharmaceuticals
1.0$22.61flat$0.00N/A0.00
CUV
Clinuvel Pharmaceuticals
1.0N/AN/A$0.00$38.34 million0.00High Trading Volume
Gap Down
CELZ
Creative Medical Technology
0.5$0.04flat$0.00N/A0.00Gap Down
CSL logo
CSL
CSL
0.8N/AN/A$0.00$9.98 billion0.00High Trading Volume
Gap Down
Cybin logo
CLXPF
Cybin
1.6$1.66flat$0.00N/A0.00Analyst Report
News Coverage
Gap Up
CYP
Cynata Therapeutics
0.5N/AN/A$0.00$2.59 million0.00High Trading Volume
Gap Down
CURE
Direxion Daily Healthcare Bull 3X Shares
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
Eastgate Biotech logo
ETBI
Eastgate Biotech
0.5$0.00flat$0.00N/A0.00Gap Up
EMMBF
Emblem
0.6$1.40flat$0.00N/A0.00
ENZC
Enzolytics
0.0$0.12flat$0.00N/A0.00Gap Up
EX1
Exopharm
0.6N/AN/A$0.00$2.72 million0.00High Trading Volume
Gap Down
This page was last updated on 5/8/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.